Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine celiac plexus block for pain reduction after sleeve gastrectomy
IRCT20250902067095N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Postoperative pain. Started Jun 2026; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20250902067095N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250902067095N2.